FDA finds little evidence that the generic drug leucovorin can help people with autism

The FDA approved leucovorin for treating cerebral folate deficiency, a rare brain disorder affecting folate delivery to the brain, and withdrew earlier claims that it could benefit hundreds of thousands of autistic children. FDA officials state that evidence supports its use only in patients with a specific genetic disorder.